Medical Advocates
HIV Infection/Disease
  Lipodystrophy Syndrome

 General Reports
Treatment
ARV/HAART
Hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Insulin Resistance
Quality of Life


 
HIV Metabolic Main HIV Main Page Main New/Newsworthy Home Page  
Last Update: September 06, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
       
     Books
 
  FULL-TEXT BOOK CHAPTER
Lipodystrophy Syndrome
Behrens B
HIV Medicine-2003 Hoffmann C, Kamps, BS (editors) Amedeo Group 2003
On-Line Book

          Journal Papers, Abstracts, and Commentaries

 
Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin.
Arama V, Munteanu DI, Streinu Cercel A, et al
J Endocrinol Invest. 2014 Feb 15.
 Abstract

FULL-TEXT ARTICLE
 Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome.
Pérez-Matute P, Pérez-Martínez L, Blanco JR, Oteo JA.
Oxid Med Cell Longev. 2013;2013:493413
 Paper

How to diagnose a lipodystrophy syndrome.
Vantyghem MC, Balavoine AS, Douillard C, et al
Ann Endocrinol (Paris). 2012 Jun 27
 Abstract

Change in Body Compositions in Female Patients with Human Immunodeficiency Virus related
Lipodystrophy Syndrome.
Jin-Peng Y, Wei Y, Tai-Sheng L, et al
 Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Aug;33(4):421-6.
 Abstract

Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from
lipodystrophy to non-infectious HIV co-morbidities.
Guaraldi G, Baraboutis IG.
J Antimicrob Chemother. 2009 Jul 3
 Abstract

HIV lipodystrophy syndrome.
Valente AM, Reis AF, Machado DM,
Arq Bras Endocrinol Metabol. 2005 Dec;49(6):871-81.
 Abstract
 
Redefining lipodystrophy syndrome: risks and impact on clinical decision making.
Lichtenstein KA.
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):395-400.
 Abstract
 
Current perspectives on HIV-associated lipodystrophy syndrome.
 Milinkovic A, Martinez E. 
J Antimicrob Chemother. 2005 May 19;
 Abstract

Agreement Analysis of Variables Involved in Lipodystrophy Syndrome Definition in HIV-
Infected Patients.
Belloso WH, Quiros RE, Ivalo SA, et al.
J Acquir Immune Defic Syndr 2003 Jan 1;32(1):104-11
 Abstract

Lipodystrophy Syndrome and Self-Assessment of Well-Being and Physical Appearance in
HIV-Positive Patients.
Oette M, Juretzko P, Kroidl A, et al.
AIDS Patient Care STDS 2002 Sep;16(9):413-7
 Abstract

Metabolic basis of HIV-lipodystrophy syndrome.
Sekhar RV, Jahoor F, White AC, et al.
Am J Physiol Endocrinol Metab 2002Aug;283(2):E332-7
 Abstract

Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of
patients after 3 years of antiretroviral treatment.
Mauss S, Corzillius M, Wolf E, S
HIV Med 2002 Jan;3(1):49-55
Abstract

  
 


Syndrome of lipodystrophy, hyperlipidemia, insulin resistance, and diabetes in treated
patients with human immunodeficiency virus infection.
Graber AL.
Endocr Pract 2001 Nov-Dec;7(6):430-7
Abstract

Insulin resistance in the HIV-lipodystrophy syndrome.
Grinspoon S.
Trends Endocrinol Metab 2001Nov 1;12(9):413-9
 Abstract

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV
nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy
syndrome.
Carr A, Miller J, Law M, Cooper DA.
AIDS 2000 Feb 18;14(3):F25-32
 Abstract

  
Treatment
       
          Journal Papers, Abstracts, and Commentaries
 
  The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy
syndrome: a meta-analysis of randomized trials.
Sheth SH, Larson RJ.
BMC Infect Dis. 2010 Jun 23;10(1):183
 Abstract
Improvement in Highly Active Antiretroviral Therapy-Induced Metabolic Syndrome
by Treatment with Pioglitazone but Not with Fenofibrate: A 2 x 2 Factorial, Randomized,
Double-Blinded, Placebo-Controlled Trial.
 Gavrila A, Hsu W, Tsiodras S et al 
Clin Infect Dis. 2005 Mar 1;40(5):745-9.
Abstract		  
ARV/HAART
       

       Journal Papers, Abstracts, and Commentaries

 
HIV/Antiretroviral therapy-related Lipodystrophy Syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma.
Peraire J, López-Dupla M, Alba V,  et al 
Clin Microbiol Infect. 2015 Apr 13. pii: S1198-743X(15)00388-2
 Paper

FULL-TEXT ARTICLE
 Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy
and of HIV-1/ART-Associated Lipodystrophy Syndrome.
Domingo P, Torres-Torronteras J, Pomar V,  et al
 PLoS One. 2010 Nov 15;5(11):e13896.
 Paper

Lipodystrophy syndrome associated with antiretroviral therapy in HIV patients:
considerations for psychosocial aspects.
Fernandes AP, Sanches RS, Mill J, et al
 Rev Lat Am Enfermagem. 2007 Oct;15(5):1041-1045.
Abstract

Antiretroviral therapy and the lipodystrophy syndrome, part 2: concepts in
aetiopathogenesis.
Nolan D, John M, Mallal S.
Antivir Ther 2001 Sep;6(3):145-60
Abstract
 

  

           Conference Reports, Abstracts, and Posters

  Cumulative nucleoside exposure as a prognostic marker for development of HIV-
associated lipodystrophy syndrome
WF Pewen, BC Calhoun, SA Riddler, et al,
 (15IAC)
 Abstract
 
Lipodystrophy syndrome in HIV infected patients taking a NRTI combination, partial
reversion with a one-week on/off treatment, Oxygen assay, results at 48 weeks
G Hittinger, C Poggi, J M Beyssac, et al
 (15IAC)
 Abstract
 
Outcomes of switching from PI-containing regimens to PI-sparing regimens due to
lipodystrophy
MP Lee, GWB Ng, RWY Chung, et al
 (15IAC)
 Abstract
Hypertriglyceridemia
       
          Journal Papers, Abstracts, and Commentaries
 
 
Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the
expression of chemokine genes in circulating leukocytes.
Alonso-Villaverde C, Aragones G, Beltran-Debon R, et al
AIDS Res Ther. 2009 Nov 23;6(1):26
 Abstract

Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir
-containing regimen: an index of atherogenicity?
Badiou S, Merle De Boever C, et al.
Atherosclerosis 2003 May;168(1):107-13
 Abstract		  

Peripheral Lipodystrophy
       
Quality of Life
       

       Journal Papers, Abstracts, and Commentaries

 
Health related quality of life and lipodystrophy syndrome among HIV-infected patients.
Preau M, Bouhnik AD, Spire B, et al 
Encephale. 2006 Oct;32(5 Pt 1):713-9
 Abstract

A qualitative study of the psychosocial implications of lipodystrophy syndrome on
HIV positive individuals.
Power R, Tate HL, McGill SM, Taylor C.
 Sex Transm Infect 2003 Apr;79(2):137-141
 Abstract

Lipodystrophy Syndrome and Self-Assessment of Well-Being and Physical
Appearance in HIV-Positive Patients.
Oette M, Juretzko P, Kroidl A, et al.
AIDS Patient Care STDS 2002 Sep;16(9):413-7
 Abstract

 

           Conference Reports, Abstracts, and Posters

  Quality of life and related psychological factors in HIV-infected patients with
Lipodystrophy Syndrome
A Marin, J L Casado, J Moya, et al
 (15IAC)
 Abstract
 
  Depression as consequence of the lipodystrophy syndrome in HIV-infected patients
A Marin, J L Casado, J Moya, 3et al
 (15IAC)
 Abstract

HIV Metabolic Main HIV Main Page Main New/Newsworthy Home Page  

HIV-Associated Lipodystrophy Syndrome